Ma Dingyuan, Chen Yulin, Sun Yun, Yang Bing, Cheng Jian, Huang Meilian, Zhang Jin, Zhang Jingjing, Hu Ping, Lin Ying, Jiang Tao, Xu Zhengfeng
State Key Laboratory of Reproductive Medicine, Department of Prenatal Diagnosis, Nanjing Maternity and Child Health Care Hospital Affiliated to Nanjing Medical University, Nanjing 210029, China.
State Key Laboratory of Reproductive Medicine, Department of Prenatal Diagnosis, Nanjing Maternity and Child Health Care Hospital Affiliated to Nanjing Medical University, Nanjing 210029, China.
Clin Biochem. 2014 Apr;47(6):455-63. doi: 10.1016/j.clinbiochem.2014.01.019. Epub 2014 Feb 3.
21-Hydroxylase deficiency (21-OHD) is the most common cause of congenital adrenal hyperplasia (CAH), a family of autosomal recessive disorders involving impaired cortisol synthesis. This study aimed to design a reliable and rational approach for identifying mutations in the CYP21A2 gene and to characterize the molecular basis of 21-OHD in 30 Chinese patients.
Copy number variations were investigated by multiplex ligation-dependent probe amplification (MLPA). Locus-specific polymerase chain reaction (PCR)/restriction endonuclease analysis was then used to verify CYP21A2 rearrangement products and prevent allele dropout. Direct sequencing of rearrangement products was performed to further refine recombination breakpoint locations. Direct sequencing of the entire CYP21A2 gene was used to detect microconversions.
We successfully characterized 60 CYP21A2 alleles from 30 patients with genetic defects. The most common one was intron 2 splice mutation (38.3%). Eighteen alleles with large gene deletions/conversions were identified, which accounted for nearly one-third (30.0%) of the genetic defects. Among these, three types of CYP21A1P/CYP21A2 chimeric genes (CH-1, CH-2, and CH-4) were characterized. Two novel CYP21A2 rearrangement genes were revealed and further demonstrated to be located downstream of the TNXB gene.
Our results indicate that the stepwise diagnostic procedure involving MLPA analysis, locus-specific PCR/restriction endonuclease analysis, and direct DNA sequencing can provide detailed genetic information about Chinese 21-OHD patients, which is helpful for characterizing structural rearrangements of CYP21A2.
21-羟化酶缺乏症(21-OHD)是先天性肾上腺皮质增生症(CAH)最常见的病因,CAH是一组常染色体隐性疾病,涉及皮质醇合成受损。本研究旨在设计一种可靠且合理的方法来鉴定CYP21A2基因中的突变,并阐明30例中国患者中21-OHD的分子基础。
采用多重连接依赖探针扩增技术(MLPA)研究拷贝数变异。然后使用位点特异性聚合酶链反应(PCR)/限制性内切酶分析来验证CYP21A2重排产物并防止等位基因缺失。对重排产物进行直接测序以进一步精确重组断点位置。对整个CYP21A2基因进行直接测序以检测微转换。
我们成功鉴定了30例有基因缺陷患者的60个CYP21A2等位基因。最常见的是内含子2剪接突变(38.3%)。鉴定出18个有大基因缺失/转换的等位基因,占基因缺陷的近三分之一(30.0%)。其中,鉴定出三种类型的CYP21A1P/CYP21A2嵌合基因(CH-1、CH-2和CH-4)。发现了两个新的CYP21A2重排基因,并进一步证明它们位于TNXB基因下游。
我们的结果表明,包括MLPA分析、位点特异性PCR/限制性内切酶分析和直接DNA测序的逐步诊断程序可以为中国21-OHD患者提供详细的遗传信息,这有助于阐明CYP21A2的结构重排。